查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197317

交互式傷口敷料市場——增長、趨勢和預測 (2023-2028)

Interactive Wound Dressing Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計交互式傷口敷料市場在預測期內的複合年增長率為 5.97%。

交互式傷口敷料市場早期受到 COVID-19 大流行的嚴重影響，因為主要城市的嚴格封鎖措施減少了交通並減少了傷害。我是。 但由於放寬了限制，生意正在好轉。 隨著新產品的推出和慢性傷口的增加，交互式傷口敷料的銷售額在過去兩年中有所增加。

主要亮點

  • 技術進步、越來越多的慢性傷口和越來越多的外科手術是交互式傷口敷料市場的主要驅動力。 例如，根據國際糖尿病聯合會 (IDF) 的數據，到 2022 年將有大約 5.37 億成年人（20-79 歲）患有糖尿病。 糖尿病患者總數預計到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。
  • 糖尿病的流行有助於市場增長，因為它增加了患糖尿病足潰瘍的風險。 此外，根據 IDF 2021 報告，糖尿病足潰瘍影響全球 40-6000 萬人。 因此，糖尿病足潰瘍患病率的增加可能會推動市場增長。 因此，糖尿病足潰瘍、靜脈性腿部潰瘍和壓力性潰瘍等導致慢性傷口的幾種生活方式疾病的患病率增加，估計將在未來幾年推動交互式傷口敷料市場的增長。這是關鍵因素之一。
  • 此外，交互式傷口敷料的需求量很大，因為它們為傷口癒合提供了潮濕的環境。 這些敷料有助於更快的再上皮化和膠原蛋白合成，通過在傷口床中產生缺氧來促進血管生成，降低傷口床的 pH 值，並減少傷口感染。
  • Wiley 於 2021 年 6 月發表的一篇文章討論了智能傷口敷料作為傷口護理管理新策略的重要性，以及不同類型的智能敷料在幫助傷口癒合方面的功效。文章指出正在進行調查研究。 交互式傷口敷料的這種進步將導致對傷口癒合產品的需求增加，從而在預測期內刺激市場增長。
  • 隨著主要參與者通過合併、產品發布和收購實現其戰略目標，交互式傷口癒合市場也在不斷擴大。 例如，2021 年 9 月，美國食品和藥物管理局 (USFDA) 批准了 Omeza Collagen Matrix，這是一種用於治療慢性傷口的聯合藥物和器械基質。 該批准是通過 FDA 的 510(k) 上市前通知流程獲得的。 設計基於與規則和不規則傷口床的密切接觸，以幫助自然傷口癒合。 該產品適用於單位劑量小瓶中的非治療應用。
  • 因此，由於技術進步、慢性傷口患病率上升以及手術程序增加，預計交互式傷口敷料市場在預測期內將呈現增長。 然而，高昂的治療成本和批准新技術的嚴格監管框架是阻礙市場增長的因素。

交互式傷口敷料市場趨勢

交互式傷口敷料市場預計在預測期內在慢性傷口部分增長

  • 慢性傷口是指 12 週後仍未癒合的傷口。 減緩傷口癒合的主要因素包括糖尿病、感染和長期炎症。 糖尿病會影響對傷口癒合至關重要的皮膚微環境。 足部潰瘍等慢性傷口在糖尿病患者中很常見。 例如，據 Mission Regional Medical Centers (MRCM's) 稱，目前估計有 670 萬人患有慢性傷口。 這一數字預計在未來十年內將增長 2% 以上。
  • 據估計，慢性傷口每年給醫療保健系統造成的損失超過 500 億美元。 交互式傷口護理的目的是預防慢性傷口並更快、更便宜地治療患者。 因此，考慮到交互式傷口治療管理的好處，預計該市場將在預測期內出現增長。
  • 此外，政府和私營部門在傷口護理方面的努力可能會促進市場增長。 例如，2022 年 9 月，傷口護理利益相關者聯盟宣布傷口護理利益相關者聯盟將開發皮膚傷口細胞和/或要求醫療保險和醫療補助服務中心 (CMS) 更新基於組織的產品的不當支付做法（ CTP，或“皮膚替代品”）。
  • 因此，此類與交互式傷口護理相關的建議可能會加深對傷口護理的理解，並在預測期內促進市場增長。 此外，為了保持市場競爭力，市場參與者正在積極開發新產品，推動市場增長。
  • Winner Medical 是先進傷口護理敷料的領先 OEM（原始設備製造）和 ODM（原始設備設計）製造商。 該公司的傷口護理產品在 110 多個國家/地區廣泛使用，作為管理糖尿病、行動不便、靜脈疾病、外傷、燒傷、侵入性手術等急性和慢性傷口的領先解決方案。 Winner在2022年歐洲傷口管理協會（EWMA）上展示了一整套最□□新和行業領先的傷口護理解決方案，包括透明薄膜敷料、帶SAF的邊緣矽泡沫敷料、抗菌系列產品和新型CMC敷料。
  • 此外，交通事故和傷亡人數的增加是造成慢性傷口的主要原因，預計這將推動對交互式傷口敷料的需求並促進市場增長。 例如，根據英國政府的 2021 年更新，2021 年英國道路交通傷亡報告中有 133 例深穿透傷。
  • 由於慢性傷口的增加以及政府和私營部門與傷口癒合相關的舉措，預計慢性傷口部分在預測期內將會增長。

預計在預測期內北美的交互式傷口敷料市場將增長

  • 由於慢性傷口患病率增加、醫療基礎設施不斷發展以及外科手術增多等因素，預計北美的交互式傷口敷料市場將出現增長。 特別是在美國，糖尿病患者的比例越來越高，糖尿病潰瘍可能會增加。
  • 根據 IDF 2021 年發布的數據，2021 年加拿大 0-14 歲兒童的糖尿病發病率（每 10 萬人）約為 37.9%。 到 2021 年，加拿大約有 300 萬 20-79 歲的成年人患有糖尿病。 因此，由於加拿大糖尿病負擔日益加重，交互式傷口護理敷料市場有望在預測期內實現健康增長。
  • 競爭對手、收購和合併的存在推動了市場增長。 例如，2022 年 3 月，ConvaTec 醫療產品和技術業務集團收購了美國醫療設備公司 Triad Life Sciences。 Triad 團隊目前的產品組合和產品線已轉移到 ConvaTec 的高級傷口護理 (AWC) 業務，現稱為 ConvaTec Advanced Tissue Technologies。
  • 2022 年 10 月，Collagen Matrix 收購了 Polyganics。 Polyganics 是一家開發和製造生物可吸收醫療器械的醫療技術公司。 此次收購擴大了公司用於膠原蛋白基質骨骼和組織修復的生物可吸收解決方案和技術平台的產品組合，開闢了新的市場和臨床機會。
  • 因此，由於慢性傷口的增加、醫療保健基礎設施的加強以及外科手術的增加，預計北美的交互式傷口敷料市場在預測期內將會擴大。

交互式傷口敷料市場競爭對手分析

大多數交互式傷口敷料產品均由世界領先的公司生產，市場競爭激烈。 擁有更多研究資金和更好的分銷系統的市場領導者正在市場中站穩腳跟。 主要參與者包括 B. Braun Melsungen AG、3M、Cardinal Health, Inc、Smith & Nephew 和 Coloplast。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 壓瘡和糖尿病足的發病率增加
    • 手術次數增加
    • 交互式傷口敷料研究和技術進步
  • 市場製約因素
    • 高級交互式傷口敷料成本高
    • 嚴格的監管政策
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按類型
    • 半透膜敷料
    • 半透性泡沫敷料
    • 水凝膠
  • 通過使用
    • 急性傷口
    • 慢性傷口
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • 3M
    • B. Braun Melsungen AG
    • Cardinal Health, Inc
    • Coloplast
    • Integra Lifesciences
    • Johnson & Johnson
    • MediWound
    • Seton Pharmaceuticals
    • Smith & Nephew
    • PAUL HARTMANN AG
    • Molnlycke Health Care AB
    • Mativ Holdings（Scapa）

第7章 市場機會與今後動向

簡介目錄
Product Code: 67463

The interactive wound dressing market is expected to register a CAGR of 5.97% over the forecast period.

The interactive wound dressing market was severely affected by the COVID-19 pandemic in the initial phases as strict lockdown measures across major cities resulted in less transportation or less incidence of injuries. However, the business has been recovering since the limitations were relaxed. Sales of interactive wound dressings have increased over the past two years, new products have also been introduced, and chronic wounds are increasingly common.

Key Highlights

  • Technological advances, the rising prevalence of chronic wounds, and an increasing number of surgical procedures mainly drive the interactive wound dressing market. For instance, according to International Diabetic Federation (IDF), in 2022, approximately 537 million adults (20-79 years) will be living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
  • The prevalence of diabetes increases the risk of diabetic foot ulcers, thus contributing to the market's growth. Moreover, as per the IDF 2021 report, diabetic foot ulcers affected 40 to 60 million people globally. As a result, the market is likely to grow due to the increased prevalence of diabetic foot ulcers. Hence, the growing prevalence of several lifestyle disorders leading to chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, is one of the key factors estimated to encourage the growth of the interactive wound dressing market in the coming years.
  • Moreover, interactive wound dressings are in high demand as these dressings provide a moist environment for wound healing. These dressings help in faster re-epithelialization, and collagen synthesis, promote angiogenesis by creating hypoxia to the wound bed, and decrease wound bed pH, which reduces wound infection.
  • An article published in June 2021 by Wiley stated ongoing studies investigating the significance of smart wound dressings as an emerging strategy for wound care management and the effectiveness of different smart dressing types for aiding wound healing. As a result of these advancements in interactive wound dressing, the need for wound healing products increases, spurring market growth during the forecast period.
  • The market for interactive wound healing is also growing as key players carry out their strategic goals through mergers, product launches, and acquisitions. For instance, in September 2021, the United States Food and Drug Administration (USFDA) cleared the Omeza Collagen Matrix, a drug-device combination matrix for chronic wound care. The approval was granted through the FDA 510(k) premarket notification process. The design is based on intimate contact with regular and irregular wound beds to aid natural wound healing. The product is a no-prep application accessible in unit dose vials.
  • Hence, the interactive wound dressing market is anticipated to witness growth during the forecast period due to technological advancements, the rising prevalence of chronic wounds, and an increasing number of surgical procedures. However, the high cost associated with the treatment and stringent regulatory framework for approval of the new technologies serve as factors that hinder the market growth.

Interactive Wound Dressing Market Trends

Chronic Wounds Segment is Expected to Witness a Growth in the Interactive Wound Dressing Market Over the Forecast Period

  • Chronic wounds are wounds that remain unhealed even after 12 weeks. The main factors delaying wound repair include diabetes, infections, and long-term inflammation. Diabetes mellitus affects the skin's microenvironment, essential for wound healing. Chronic wounds such as foot ulcers are prevalent among the population with diabetes. For instance, according to Mission Regional Medical Center (MRCM's), it is estimated that 6.7 million people currently live with chronic wounds. That number is expected to grow by more than two percent in the next decade.
  • The annual cost of chronic wounds to the healthcare system exceeds USD 50 billion. Interactive wound care aims to prevent chronic wounds and heal patients more quickly and affordably. Hence, considering the advantages of interactive wound care management, the market is anticipated to witness growth during the forecast period.
  • Furthermore, government and private agencies' initiatives associated with wound healing are likely to boost market growth. For instance, in September 2022, the Alliance of Wound Care Stakeholders urged the Centers for Medicare and Medicaid Services (CMS) to update inadequate payment methodologies for cellular and/or tissue-based products for skin wounds (CTPs, or "skin substitutes") to ensure appropriate access to care in the hospital outpatient/provider-based department (PBD) site of service.
  • Hence, such recommendations associated with interactive wound care are likely to provide a better understanding of wound care, thereby boosting the market growth over the forecast period. Moreover, market players are actively innovating new products to maintain the competition, likely promoting the market growth.
  • Winner Medical is a top original equipment manufacturer (OEM) and original design manufacturer (ODM) advanced wound care dressing manufacturer. Its wound care products have been widely used in more than 110 countries as primary solutions to provide wound management for acute and chronic wounds resulting from diabetes, immobility and venous disease, as well as from traumatic injury, burns, invasive surgery and other causes. Winner showcased its complete set latest and industry-leading advanced wound care solutions such as transparent film dressing, bordered silicone foam dressing with SAF and antibiosis series products and its new product,the CMC dressing at the European Wound Management Association (EWMA) 2022.
  • Furthermore, the rise in road accidents and casualties, which is a major source of chronic wounds, is anticipated to drive the demand for interactive wound dressing, thereby boosting market growth. For instance, according to a 2021 update from the Government of the UK, 133 deep penetrating wounds were reported from road casualties in Great Britain in 2021.
  • As a result of the increase in the number of chronic wounds and government and private sector initiatives related to wound healing, the chronic wounds segment is expected to witness growth during the forecast period.

North America is Expected to Witness a Growth in the Interactive Wound Dressing Market Over the Forecast Period

  • North America is expected to witness growth in the interactive wound dressing market owing to the factors such as the growing prevalence of chronic wounds, better healthcare infrastructure, and a rising number of surgical procedures in the region. The increase in the prevalence of diabetic populations in the country, especially in the United States, indicates that there are chances of rising diabetic ulcers.
  • As per the data published by IDF in 2021, the incidence of diabetes in Canada (per 100,000) for 2021 was around 37.9% in children aged between 0-14 years. In addition, the number of adults aged 20-79 years suffering from diabetes in Canada was around 3 million for the year 2021. Therefore, with the increasing burden of diabetes in Canada, the interactive wound care dressing market is expected to witness healthy growth over the forecast period.
  • The presence of competitors, acquisitions, and mergers boost the market growth. For instance, in March 2022, the medical products and technologies business ConvaTec Group acquired Triad Life Sciences, a US-focused medical device company. The Triad team's current portfolio and product pipeline was transferred to ConvaTec's Advanced Wound Care (AWC) business, and is now known as ConvaTec Advanced Tissue Technologies.
  • Furthermore, in October 2022, Collagen Matrix, Inc. acquired Polyganics. Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices. The acquisition expands Collagen Matrix's portfolio of bioresorbable solutions and technology platforms for bone and tissue repair, unlocking new markets and clinical opportunities for the company.
  • As a result, the growing prevalence of chronic wounds, enhanced healthcare infrastructure, and increased surgical operations are anticipated to boost North America's interactive wound dressing market over the forecast period.

Interactive Wound Dressing Market Competitor Analysis

The majority of interactive wound dressing products are being manufactured by the global key players and the market is moderately competitive in nature. Market leaders with more funds for research and better distribution system have established their position in the market. The major key players are B. Braun Melsungen AG, 3M, Cardinal Health, Inc, Smith & Nephew, and Coloplast among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidence of Pressure Ulcers and Diabetic Foot
    • 4.2.2 Increasing Number of Surgical Procedures
    • 4.2.3 Increasing Research and Technological Advancements in Interactive Dressings
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Advanced Interactive Wound Dressings
    • 4.3.2 Stringent Regulatory Policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Semi-permeable Films Dressing
    • 5.1.2 Semi-permeable Foams Dressing
    • 5.1.3 Hydrogel
  • 5.2 By Application
    • 5.2.1 Acute Wounds
    • 5.2.2 Chronic Wounds
  • 5.3 By End-User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Cardinal Health, Inc
    • 6.1.4 Coloplast
    • 6.1.5 Integra Lifesciences
    • 6.1.6 Johnson & Johnson
    • 6.1.7 MediWound
    • 6.1.8 Seton Pharmaceuticals
    • 6.1.9 Smith & Nephew
    • 6.1.10 PAUL HARTMANN AG
    • 6.1.11 Molnlycke Health Care AB
    • 6.1.12 Mativ Holdings (Scapa)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS